A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures

NCT00387686 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
367
Enrollment
INDUSTRY
Sponsor class

Stopped Decision was taken by Wyeth Sr. Management to early terminate the 3100N7-210 study (terminate enrollment but complete follow-up).

Conditions

Interventions

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer